/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | CCCCC4 Therapeutics, Inc | NVDANVIDIA CORP | TSLATesla, Inc. | AAPLApple Inc. | PLTRPalantir Technologie |
|---|---|---|---|---|---|
| Last close | $3.37 | $204.64 | $399.81 | $344.63 | $184.11 |
| Change % | +2.12% | -4.22% | -0.87% | -1.23% | -6.27% |
| Market cap | $415M | $4.93T | $1.58T | $5.03T | $442.4B |
| P/E | — | 41.8 | 370.2 | 46.2 | 292.2 |
| Revenue | $36M | $215.9B | $94.8B | $416.2B | $4.5B |
| Rev growth (YoY) | 1.0% | 65.5% | -2.9% | 6.4% | 56.2% |
| Net income | $-104994000 | $120.1B | $3.9B | $112.0B | $1.6B |
| Net margin | -292.1% |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Green = best in the row among the compared names. Educational only — not investment advice.
| 55.6% |
| 4.1% |
| 26.9% |
| 36.3% |
| EPS (diluted) | $-1.27 | $4.90 | $1.08 | $7.46 | $0.63 |
| Piotroski F-ScoreUNVALIDATED | 3 | 4 | 5 | 8 | 7 |
| Altman Z-ScoreUNVALIDATED | -0.66 | 64.43 | 18.77 | 12.84 | 189.37 |
| Beneish M-ScoreUNVALIDATED | — | -1.15 | — | -2.29 | — |
| Next earnings | open now | 11-13 → 11-23 | 01-22 → 02-01 | open now | open now |